Fellowship · Pittsburgh, PA
Sponsored by Zitelli and Brodland Clinic
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma.
Journal of the American Academy of Dermatology · 2025 · 20 citations · David Brodland, Tyler Willenbrink
Cutaneous interaction with visible light: What do we know?
Journal of the American Academy of Dermatology · 2023 · 24 citations · Mona Sadeghpour
Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes.
Journal of the American Academy of Dermatology · 2026 · 8 citations · David Brodland, John Zitelli, Tyler Willenbrink
Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma.
Journal of the American Academy of Dermatology · 2021 · 79 citations · David Panther, David Brodland, John Zitelli
Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma.
JAMA dermatology · 2025 · 16 citations · David Brodland, Tyler Willenbrink
Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Journal of the American Academy of Dermatology · 2023 · 25 citations · David Brodland, John Zitelli
Postoperative Complications After Interpolated Flap Repair for Mohs Defects of the Nose: A Multicenter Prospective Cohort Study.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2023 · 9 citations · Christine Weinberger
Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: A multicenter retrospective study.
Journal of the American Academy of Dermatology · 2025 · 9 citations · David Brodland, John Zitelli, Tyler Willenbrink